{
    "functional_evidence_assessment": [
        {
            "variant_id": {
                "Gene": "PARK2",
                "Protein_Change": {
                    "ref": "W",
                    "alt": "Stop",
                    "position": "453"
                },
                "variant_string_id": "PARK2 W453Stop"
            },
            "functional_evidence_aim": "Pathogenic",
            "assessment_steps": [
                {
                    "step_name": "Step 1: Define the disease mechanism",
                    "extracted_paper_info": "Loss of parkin function is the major cause of autosomal recessive Parkinson's disease (ARPD). Inactivation of parkin leads to the accumulation of parkin substrates, such as CDCrel - 1 and Pael - R, which ultimately might damage dopaminergic neurones.",
                    "judgment": "Yes",
                    "reasoning": "The paper clearly states that loss of parkin function causes ARPD and describes how inactivation leads to substrate accumulation and neuronal damage, thus defining the disease mechanism.",
                    "next_step_or_outcome": "Proceed to Step 2"
                },
                {
                    "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
                    "extracted_paper_info": "Assays used include detergent solubility assay, sucrose gradient analysis, Renografin density gradient centrifugation, metabolic labelling, immunoprecipitation, ubiquitination assay. These assays are used to study folding, aggregation, cellular localization, and E3 ligase activity of parkin mutants.",
                    "judgment": "Yes",
                    "reasoning": "The assays effectively model aspects of the disease mechanism. For example, detergent solubility and sedimentation assays show misfolding and aggregation related to parkin inactivation, and the ubiquitination assay measures E3 ligase activity which is relevant to the disease mechanism. ",
                    "next_step_or_outcome": "Proceed to Step 3"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays - Sub - step 3a: Basic Controls and Replicates",
                    "extracted_paper_info": "For metabolic labelling and immunoprecipitation, quantitative analysis was performed using AIDA 3.26 image analysis software from at least three independent experiments. However, it is not clear if both normal/negative/wild - type and abnormal/positive/null controls were used in all assays.",
                    "judgment": "No",
                    "reasoning": "While multiple replicates were used in some assays, the use of both types of controls is not clearly established for all assays, so we proceed to Sub - step 3b.",
                    "next_step_or_outcome": "Proceed to Sub - step 3b"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays - Sub - step 3b: Accepted/Validated Assay (if basic controls/replicates were insufficient in 3a)",
                    "extracted_paper_info": "The assays like detergent solubility, western blot, immunoprecipitation, etc., are standard techniques in the field of protein biochemistry.",
                    "judgment": "Yes",
                    "reasoning": "The assays used are broadly accepted historically as standard techniques in protein biochemistry, so the functional evidence strength is Max PS3_supporting.",
                    "next_step_or_outcome": "Max PS3_supporting"
                }
            ],
            "final_evidence_strength": {
                "type": "Pathogenic",
                "strength": "PS3_supporting"
            },
            "overall_conclusion": "Based on the analysis, the functional evidence for the PARK2 W453Stop variant is considered supporting (PS3_supporting) as the assays are standard in the field but do not fully meet the basic controls and replicates criteria."
        },
        {
            "variant_id": {
                "Gene": "PARK2",
                "Protein_Change": {
                    "ref": "E",
                    "alt": "Stop",
                    "position": "409"
                },
                "variant_string_id": "PARK2 E409Stop"
            },
            "functional_evidence_aim": "Pathogenic",
            "assessment_steps": [
                {
                    "step_name": "Step 1: Define the disease mechanism",
                    "extracted_paper_info": "Loss of parkin function is the major cause of autosomal recessive Parkinson's disease (ARPD). Inactivation of parkin leads to the accumulation of parkin substrates, such as CDCrel - 1 and Pael - R, which ultimately might damage dopaminergic neurones.",
                    "judgment": "Yes",
                    "reasoning": "The paper clearly defines the disease mechanism as loss of parkin function causing ARPD through substrate accumulation and neuronal damage.",
                    "next_step_or_outcome": "Proceed to Step 2"
                },
                {
                    "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
                    "extracted_paper_info": "Assays such as detergent solubility assay, sucrose gradient, Renografin density gradient centrifugation were used to study folding, aggregation, and cellular localization of the mutant.",
                    "judgment": "Yes",
                    "reasoning": "These assays are relevant to the disease mechanism as they help understand how the mutant leads to parkin inactivation, which is related to the disease pathogenesis.",
                    "next_step_or_outcome": "Proceed to Step 3"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays - Sub - step 3a: Basic Controls and Replicates",
                    "extracted_paper_info": "Quantitative analysis was from at least three independent experiments in some assays, but it's unclear if both normal/negative/wild - type and abnormal/positive/null controls were used.",
                    "judgment": "No",
                    "reasoning": "Although there were replicates in some assays, the use of both types of controls is not clear, so we move to Sub - step 3b.",
                    "next_step_or_outcome": "Proceed to Sub - step 3b"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays - Sub - step 3b: Accepted/Validated Assay (if basic controls/replicates were insufficient in 3a)",
                    "extracted_paper_info": "The assays used, like detergent solubility and density gradient centrifugation, are standard techniques in protein research.",
                    "judgment": "Yes",
                    "reasoning": "These are broadly accepted historical techniques in the field, so the functional evidence strength is Max PS3_supporting.",
                    "next_step_or_outcome": "Max PS3_supporting"
                }
            ],
            "final_evidence_strength": {
                "type": "Pathogenic",
                "strength": "PS3_supporting"
            },
            "overall_conclusion": "The functional evidence for the PARK2 E409Stop variant is PS3_supporting because the assays are standard in the field but lack clear evidence of complete basic controls and replicates."
        },
        {
            "variant_id": {
                "Gene": "PARK2",
                "Protein_Change": {
                    "ref": "Q",
                    "alt": "Stop",
                    "position": "311"
                },
                "variant_string_id": "PARK2 Q311Stop"
            },
            "functional_evidence_aim": "Pathogenic",
            "assessment_steps": [
                {
                    "step_name": "Step 1: Define the disease mechanism",
                    "extracted_paper_info": "Loss of parkin function is the major cause of autosomal recessive Parkinson's disease (ARPD). Inactivation of parkin leads to the accumulation of parkin substrates, such as CDCrel - 1 and Pael - R, which ultimately might damage dopaminergic neurones.",
                    "judgment": "Yes",
                    "reasoning": "The paper clearly defines the disease mechanism related to parkin inactivation and its consequences for ARPD.",
                    "next_step_or_outcome": "Proceed to Step 2"
                },
                {
                    "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
                    "extracted_paper_info": "Assays including detergent solubility and analysis of cellular localization were used to study the mutant.",
                    "judgment": "Yes",
                    "reasoning": "These assays are relevant to understanding how the mutant contributes to parkin inactivation, which is in line with the disease mechanism.",
                    "next_step_or_outcome": "Proceed to Step 3"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays - Sub - step 3a: Basic Controls and Replicates",
                    "extracted_paper_info": "There is mention of multiple experiments, but no clear indication of using both normal/negative/wild - type and abnormal/positive/null controls.",
                    "judgment": "No",
                    "reasoning": "Lack of clear evidence of using both types of controls, despite some replication, leads us to Sub - step 3b.",
                    "next_step_or_outcome": "Proceed to Sub - step 3b"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays - Sub - step 3b: Accepted/Validated Assay (if basic controls/replicates were insufficient in 3a)",
                    "extracted_paper_info": "The assays like detergent solubility assay are standard in protein biochemistry research.",
                    "judgment": "Yes",
                    "reasoning": "As these are well - established techniques in the field, the functional evidence strength is Max PS3_supporting.",
                    "next_step_or_outcome": "Max PS3_supporting"
                }
            ],
            "final_evidence_strength": {
                "type": "Pathogenic",
                "strength": "PS3_supporting"
            },
            "overall_conclusion": "For the PARK2 Q311Stop variant, the functional evidence is PS3_supporting as the assays are standard but do not fully meet the basic controls and replicates requirements."
        },
        {
            "variant_id": {
                "Gene": "PARK2",
                "Protein_Change": {
                    "ref": "R",
                    "alt": "Q",
                    "position": "33"
                },
                "variant_string_id": "PARK2 R33Q"
            },
            "functional_evidence_aim": "Pathogenic",
            "assessment_steps": [
                {
                    "step_name": "Step 1: Define the disease mechanism",
                    "extracted_paper_info": "Loss of parkin function is the major cause of autosomal recessive Parkinson's disease (ARPD). Inactivation of parkin leads to the accumulation of parkin substrates, such as CDCrel - 1 and Pael - R, which ultimately might damage dopaminergic neurones.",
                    "judgment": "Yes",
                    "reasoning": "The paper clearly defines the disease mechanism associated with parkin inactivation and ARPD.",
                    "next_step_or_outcome": "Proceed to Step 2"
                },
                {
                    "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
                    "extracted_paper_info": "Assays like metabolic labelling, immunoprecipitation, and ubiquitination assay were used to study the stability and E3 ligase activity of the mutant.",
                    "judgment": "Yes",
                    "reasoning": "These assays are relevant to understanding how the mutant leads to parkin inactivation, which is related to the disease mechanism.",
                    "next_step_or_outcome": "Proceed to Step 3"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays - Sub - step 3a: Basic Controls and Replicates",
                    "extracted_paper_info": "Quantitative analysis was from at least three independent experiments, but it's not clear if both normal/negative/wild - type and abnormal/positive/null controls were used.",
                    "judgment": "No",
                    "reasoning": "Although there were replicates, the use of both types of controls is not clear, so we move to Sub - step 3b.",
                    "next_step_or_outcome": "Proceed to Sub - step 3b"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays - Sub - step 3b: Accepted/Validated Assay (if basic controls/replicates were insufficient in 3a)",
                    "extracted_paper_info": "Metabolic labelling, immunoprecipitation, and ubiquitination assays are standard techniques in protein research.",
                    "judgment": "Yes",
                    "reasoning": "These are widely accepted techniques in the field, so the functional evidence strength is Max PS3_supporting.",
                    "next_step_or_outcome": "Max PS3_supporting"
                }
            ],
            "final_evidence_strength": {
                "type": "Pathogenic",
                "strength": "PS3_supporting"
            },
            "overall_conclusion": "The functional evidence for the PARK2 R33Q variant is PS3_supporting as the assays are standard but lack clear evidence of complete basic controls and replicates."
        },
        {
            "variant_id": {
                "Gene": "PARK2",
                "Protein_Change": {
                    "ref": "R",
                    "alt": "P",
                    "position": "42"
                },
                "variant_string_id": "PARK2 R42P"
            },
            "functional_evidence_aim": "Pathogenic",
            "assessment_steps": [
                {
                    "step_name": "Step 1: Define the disease mechanism",
                    "extracted_paper_info": "Loss of parkin function is the major cause of autosomal recessive Parkinson's disease (ARPD). Inactivation of parkin leads to the accumulation of parkin substrates, such as CDCrel - 1 and Pael - R, which ultimately might damage dopaminergic neurones.",
                    "judgment": "Yes",
                    "reasoning": "The paper clearly defines the disease mechanism related to parkin inactivation and ARPD.",
                    "next_step_or_outcome": "Proceed to Step 2"
                },
                {
                    "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
                    "extracted_paper_info": "Assays including metabolic labelling, immunoprecipitation, detergent solubility, and ubiquitination assay were used to study the mutant's stability, folding, and E3 ligase activity.",
                    "judgment": "Yes",
                    "reasoning": "These assays are relevant to understanding how the mutant contributes to parkin inactivation, which is in line with the disease mechanism.",
                    "next_step_or_outcome": "Proceed to Step 3"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays - Sub - step 3a: Basic Controls and Replicates",
                    "extracted_paper_info": "There is mention of multiple independent experiments, but no clear indication of using both normal/negative/wild - type and abnormal/positive/null controls.",
                    "judgment": "No",
                    "reasoning": "Despite some replication, lack of clear evidence of using both types of controls leads us to Sub - step 3b.",
                    "next_step_or_outcome": "Proceed to Sub - step 3b"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays - Sub - step 3b: Accepted/Validated Assay (if basic controls/replicates were insufficient in 3a)",
                    "extracted_paper_info": "The assays used are standard techniques in protein biochemistry, such as metabolic labelling, immunoprecipitation, etc.",
                    "judgment": "Yes",
                    "reasoning": "As these are well - established techniques in the field, the functional evidence strength is Max PS3_supporting.",
                    "next_step_or_outcome": "Max PS3_supporting"
                }
            ],
            "final_evidence_strength": {
                "type": "Pathogenic",
                "strength": "PS3_supporting"
            },
            "overall_conclusion": "For the PARK2 R42P variant, the functional evidence is PS3_supporting because the assays are standard but do not fully meet the basic controls and replicates criteria."
        },
        {
            "variant_id": {
                "Gene": "PARK2",
                "Protein_Change": {
                    "ref": "K",
                    "alt": "A",
                    "position": "48"
                },
                "variant_string_id": "PARK2 K48A"
            },
            "functional_evidence_aim": "Pathogenic",
            "assessment_steps": [
                {
                    "step_name": "Step 1: Define the disease mechanism",
                    "extracted_paper_info": "Loss of parkin function is the major cause of autosomal recessive Parkinson's disease (ARPD). Inactivation of parkin leads to the accumulation of parkin substrates, such as CDCrel - 1 and Pael - R, which ultimately might damage dopaminergic neurones.",
                    "judgment": "Yes",
                    "reasoning": "The paper clearly defines the disease mechanism associated with parkin inactivation and ARPD.",
                    "next_step_or_outcome": "Proceed to Step 2"
                },
                {
                    "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
                    "extracted_paper_info": "Assays like metabolic labelling, immunoprecipitation were used to study the stability of the mutant.",
                    "judgment": "Yes",
                    "reasoning": "These assays are relevant to understanding